A phase III , randomized, double-blind, double-dummy multicenter study to evaluate the efficacy and safety of 775 mg APC-111 [amoxicillin] MP tablet QD for 7 days vs penicillin VK [phenoxymethylpenicillin potassium] 250mg QID for 10 days in patients with Streptococcus pyogenes

Trial Profile

A phase III , randomized, double-blind, double-dummy multicenter study to evaluate the efficacy and safety of 775 mg APC-111 [amoxicillin] MP tablet QD for 7 days vs penicillin VK [phenoxymethylpenicillin potassium] 250mg QID for 10 days in patients with Streptococcus pyogenes

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Sep 2005

At a glance

  • Drugs Amoxicillin; Phenoxymethylpenicillin potassium
  • Indications Pharyngitis; Streptococcal infections; Tonsillitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top